Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
As of today (2026-07-21), the Forward Annual Dividend Yield of Kaken Pharmaceutical Co is 4.92%.
As of today (2026-07-21), the Trailing Annual Dividend Yield of Kaken Pharmaceutical Co is 4.92%.
TSE:4521's Forward Dividend Yield % is ranked better than 86.11% of 511
companies
in the Drug Manufacturers industry
Industry Median: 2.03
vs TSE:4521: 4.92
During the past 12 months, Kaken Pharmaceutical Co's average Dividends Per Share Growth Rate was 26.70% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 8.20% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 3.40% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 1.50% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Kaken Pharmaceutical Co was 20.80% per year. The lowest was 0.00% per year. And the median was 13.50% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Kaken Pharmaceutical Co (TSE:4521) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Kaken Pharmaceutical Co Forward Dividend Yield % Related Terms
TSE:4521 vs ZTS, UTHR: Forward Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Kaken Pharmaceutical Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kaken Pharmaceutical Co Forward Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kaken Pharmaceutical Co's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Kaken Pharmaceutical Co's Forward Dividend Yield % falls into.
Kaken Pharmaceutical Co Forward Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Kaken Pharmaceutical Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
JPY 95.000000
2026-03-30
2026-03-31
2026-06-29
Cash Dividend
semi-annually
JPY:JPY 1.000000
JPY 95.000000
2025-09-29
2025-09-30
2025-11-28
Cash Dividend
semi-annually
JPY:JPY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 4.92% mean?
Kaken Pharmaceutical Co (TSE:4521) has a Forward Dividend Yield % of 4.92% as of Jul. 21, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Kaken Pharmaceutical Co and its competitors. According to the industry distribution chart, Kaken Pharmaceutical Co ranks #71 out of 511 companies in the Drug Manufacturers industry, placing it in the top 13.9%.
Is Kaken Pharmaceutical Co's Forward Dividend Yield % too high?
Kaken Pharmaceutical Co's current Forward Dividend Yield % is 4.92%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.03. Kaken Pharmaceutical Co's value of 4.92% is 142.4% above this industry median. Based on the distribution chart, Kaken Pharmaceutical Co ranks #71 out of 511 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Kaken Pharmaceutical Co has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kaken Pharmaceutical Co's Forward Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Kaken Pharmaceutical Co ranks #71 out of 511 companies for Forward Dividend Yield %. This places Kaken Pharmaceutical Co in the top 14% of its industry — outperforming the majority of peers. The industry median Forward Dividend Yield % is 2.03. Kaken Pharmaceutical Co's value of 4.92% is 142.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.03, based on 511 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kaken Pharmaceutical Co's current Forward Dividend Yield % of 4.92% is 142.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Kaken Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kaken Pharmaceutical Co's current Forward Dividend Yield % is 4.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kaken Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Kaken Pharmaceutical Co (TSE:4521) is currently considered Fairly Valued. The stock's GF Value™ is 円3,775.44, compared to a current price of 円3,900.00 — trading 3.3% above its estimated fair value. The current Forward Dividend Yield % is 4.92% and 142.4% above the Drug Manufacturers industry median of 2.03. Kaken Pharmaceutical Co's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Kaken Pharmaceutical Co (TSE:4521), the current Forward Dividend Yield % is 4.92% as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kaken Pharmaceutical Co (TSE:4521) Overvalued in 2026?
Based on GuruFocus' analysis, Kaken Pharmaceutical Co stock appears to be overvalued.
The current stock price of 円3,900.00 is trading 3.3% above its estimated GF Value™ of 円3,775.44.
GuruFocus considers Kaken Pharmaceutical Co to be Fairly Valued.
Key valuation signals for TSE:4521:
Forward Dividend Yield %: 4.92%
GF Value™: 円3,775.44 vs. price of 円3,900.00 (3.3% above fair value)
Industry Position: 142.4% above the Drug Manufacturers median (#71 of 511)
No single metric tells the full story. See the TSE:4521 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kaken Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
69GF Score
Get the complete analysis for TSE:4521
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4521 has been successfully added to your 
